Pure Global

Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55 - Albania Medical Device Registration

Access comprehensive regulatory information for Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55 in the Albania medical device market through Pure Global AI's free database. This Invitro medical device is manufactured by Abbott Laboratories Diagnostics Division, Abbott Park, Illinois 60064 USA. The device was registered on October 29, 2019.

This page provides complete registration details including product model (Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.

Free Database
Powered by Pure Global AI
Albania Official Data
Invitro
Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55
Albania Medical Device Registration
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Information

Sherben per ekstraktimin e Tacrolimus nga mostrat (kampione nga gjaku I plote I njeriut, kontrollet dhe kalibratoret Architect Cyclosporine) qe do te testohen ne sistemet ARCHITECT

Device Classification
Risk Class
Invitro
Product Model
Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55
Product Name
Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55
Registration Information
Registration Date
October 29, 2019
Analysis ID
6260